Sharon Shacham
Direktor/Vorstandsmitglied bei ACRIVON THERAPEUTICS, INC.
Vermögen: 151 119 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kristina Masson | M | 44 | 6 Jahre | |
| Peter Blume-Jensen | M | 62 | 6 Jahre | |
| Richard Paulson | M | 56 | 4 Jahre | |
| Chen Schor | M | 51 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 11 Jahre |
| Garen Bohlin | M | 76 | 11 Jahre | |
| Accumanno James | M | - | 3 Jahre | |
| Erick Gamelin | M | 67 | 3 Jahre | |
| Michael Mano | M | 47 | 4 Jahre | |
| Derek DiRocco | M | 43 | 3 Jahre | |
| Christy Oliger | F | 54 | 4 Jahre | |
| Michael Tomsicek | M | 58 | 2 Jahre | |
| Mansoor Mirza | M | 63 | 14 Jahre | |
| Mike Mason | M | 49 | 5 Jahre | |
| Deepa Pakianathan | M | 59 | 11 Jahre | |
| Barry Greene | M | 60 | 11 Jahre | |
| Katharine Peterson | F | - | - | |
| Bruce Close | M | - | - | |
| Praveen Marapaka | M | - | - | |
| Monica Phadnis | F | - | - | |
| Adam Levy | M | - | 1 Jahre | |
| Jean-Marie Cuillerot | M | - | - | |
| Karl Hsu | M | - | - | |
| Mary Miller | F | 50 | - | |
| Rasmus Holm-Jorgensen | M | 53 | 2 Jahre | |
| Ivana Magovcevic-Liebisch | M | 55 | - | |
| Brian Austad | M | - | 11 Jahre | |
| Charles Baum | M | 65 | 1 Jahre | |
| Eric Devroe | M | 46 | 2 Jahre | |
| Rajshree Kandadai | F | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Kauffman | M | 60 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 16 Jahre |
| Paul Brannelly | M | 51 | 1 Jahre | |
| Ronald DePinho | M | 69 | 4 Jahre | |
| Michael J. Todisco | M | 59 | - | |
| Joseph Araujo | M | 50 | 2 Jahre | |
| Giulio Draetta | M | - | - | |
| Gregory D. Phelps | M | 75 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 5 Jahre |
| Mikael Dolsten | M | 65 | 6 Jahre | |
| Robert B. Pelletier | M | 71 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 3 Jahre |
| Ian Karp | M | - | - | |
| Jatin Shah | M | 49 | 5 Jahre | |
| Elkan R. Gamzu | M | 81 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Stephen Knight | M | 63 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Mark Leuchtenberger | M | 67 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| J. Garland | M | 55 | 6 Jahre | |
| Lisa Meletta | F | - | - | |
| Michael Falvey | M | 65 | 2 Jahre | |
| Michael Gilman | M | 69 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Justin Renz | M | 52 | 3 Jahre | |
| Andrew C. G. Uprichard | M | 66 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 4 Jahre |
| Chris Primiano | M | 44 | 6 Jahre | |
| Kenneth E. Weg | M | 85 | - | |
| Perry Monaco | M | - | 3 Jahre | |
| Ran Frenkel | M | 55 | 8 Jahre | |
| Alan T. Barber | M | 70 | - | |
| Steven Rotman | M | - | - | |
| Kevin P. Malobisky | M | - | 2 Jahre | |
| Anand Varadan | M | 57 | 1 Jahre | |
| Tina Beamon | F | - | - | |
| Jas Uppal | M | 56 | 2 Jahre | |
| Pierre S. Sayad | M | - | - | |
| Joan Wood | F | - | 2 Jahre | |
| Amer Alghabban | M | - | - | |
| lee Giguere | M | 43 | 3 Jahre | |
| Ronit Milstein | F | - | - | |
| Margaret S. Lee | M | - | - | |
| Yosef Landesman | M | - | - | |
| Humphrey Gardner | M | 60 | - | |
| Bruce Greenberg | M | 56 | 2 Jahre | |
| David Frawley | M | - | - | |
| Stephen Mitchener | M | 45 | - | |
| Stanley Crooke | M | 78 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 10 Jahre |
| Simon S. Jones | M | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Ed Roberts | M | - | - | |
| Ian Smith | M | 58 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Thomas C. K. Chan | M | 68 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 3 Jahre |
| Robert Perez | M | 59 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 3 Jahre |
| Tanya Lewis | F | 53 | - | |
| Peter Wirth | M | 73 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Fredrick Frank | M | 92 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Christopher F. O. Gabrieli | M | 64 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 13 Jahre |
| Michael Astrue | M | 67 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Michael Webb | M | 66 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Alan P. Carpenter | M | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Robert Mark Weisskoff | M | 61 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 6 Jahre |
| Margaret J. Uprichard | M | 65 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Pamela A. Silver | M | - | - | |
| John A. Barrett | M | 69 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 3 Jahre |
| Kimberlee Drapkin | F | 56 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 3 Jahre |
| Oren M. Becker | M | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 1 Jahre |
| Sheila DeWitt | M | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Patrick J. Fortune | M | 77 |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 2 Jahre |
| F. Carsten Thiel | M | 61 | - | |
| Efrat Shalom-Berensohn | F | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | - |
| Adam L. Muzikant | M | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 2 Jahre |
| John Demaree | M | 56 | 1 Jahre | |
| Robert Carlson | M | - | - | |
| Payman Darouian | M | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 97 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Sharon Shacham
- Persönliches Netzwerk